Deutsche Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,196
| Closed | -$1.02M | – | 4829 |
|
|
2021
Q2 | $1.02M | Sell |
6,196
-112,400
| -95% | -$18.8M | ﹤0.01% | 2752 |
|
|
2021
Q1 | $18.2M | Buy |
118,596
+109,812
| +1,250% | +$14.9M | 0.01% | 933 |
|
|
2020
Q4 | $1.1M | Sell |
8,784
-372
| -4% | -$41.6K | ﹤0.01% | 2374 |
|
|
2020
Q3 | $929K | Sell |
9,156
-112,425
| -92% | -$11.5M | ﹤0.01% | 2244 |
|
|
2020
Q2 | $11.8M | Buy |
121,581
+29,155
| +32% | +$2.71M | 0.01% | 903 |
|
|
2020
Q1 | $7.67M | Buy |
92,426
+21,189
| +30% | +$2.07M | 0.01% | 1026 |
|
|
2019
Q4 | $7.92M | Sell |
71,237
-38,774
| -35% | -$3.99M | 0.01% | 1208 |
|
|
2019
Q3 | $10.9M | Buy |
110,011
+28,063
| +34% | +$2.79M | 0.01% | 1035 |
|
|
2019
Q2 | $8.12M | Sell |
81,948
-5,917
| -7% | -$565K | ﹤0.01% | 1502 |
|
|
2019
Q1 | $9.69M | Buy |
87,865
+49,056
| +126% | +$5.13M | 0.01% | 1397 |
|
|
2018
Q4 | $3.57M | Sell |
38,809
-79,729
| -67% | -$8.07M | ﹤0.01% | 2020 |
|
|
2018
Q3 | $13.1M | Sell |
118,538
-2,158
| -2% | -$225K | 0.01% | 1423 |
|
|
2018
Q2 | $11.3M | Buy |
120,696
+15,862
| +15% | +$1.37M | 0.01% | 1643 |
|
|
2018
Q1 | $8.7M | Sell |
104,834
-20,378
| -16% | -$1.81M | ﹤0.01% | 1740 |
|
|
2017
Q4 | $11.4M | Sell |
125,212
-177,722
| -59% | -$14.8M | 0.01% | 1394 |
|
|
2017
Q3 | $23.1M | Buy |
302,934
+18,082
| +6% | +$1.37M | 0.02% | 939 |
|
|
2017
Q2 | $21.4M | Sell |
284,852
-19,546
| -6% | -$1.35M | 0.02% | 908 |
|
|
2017
Q1 | $19.9M | Buy |
304,398
+109,897
| +57% | +$6.47M | 0.01% | 882 |
|
|
2016
Q4 | $10.7M | Sell |
194,501
-38,765
| -17% | -$2.13M | 0.01% | 1210 |
|
|
2016
Q3 | $13.2M | Sell |
233,266
-96,028
| -29% | -$4.71M | 0.01% | 1118 |
|
|
2016
Q2 | $13.7M | Buy |
329,294
+296,804
| +914% | +$13.7M | 0.01% | 1109 |
|
|
2016
Q1 | $1.39M | Buy |
32,490
+14,793
| +84% | +$625K | ﹤0.01% | 2598 |
|
|
2015
Q4 | $799K | Sell |
17,697
-18,687
| -51% | -$785K | ﹤0.01% | 3026 |
|
|
2015
Q3 | $1.41M | Buy |
36,384
+25,564
| +236% | +$1.02M | ﹤0.01% | 2717 |
|
|
2015
Q2 | $392K | Buy |
10,820
+1,917
| +22% | +$60.6K | ﹤0.01% | 3531 |
|
|
2015
Q1 | $255K | Sell |
8,903
-85,389
| -91% | -$2.38M | ﹤0.01% | 3669 |
|
|
2014
Q4 | $2.28M | Buy |
+94,292
| New | +$2.13M | ﹤0.01% | 2574 |
|
Other funds holding PRAH
Deutsche Bank's PRAH Position: Q3 2021 in Review
Deutsche Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 6,196 shares — an estimated $1.02M sold.
Deutsche Bank first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $23.1M in Q3 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Deutsche Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Deutsche Bank sold 6,196 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.02M.
- Deutsche Bank first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Deutsche Bank's PRA Health Sciences, Inc. position peaked at $23.1M in Q3 2017.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.